NEW YORK, Nov. 16 – Bioinformatics and database company Gene Logic said Friday it expects its revenues for full-year 2002 to total $65 million, a 52 percent increase over anticipated revenues for this year.

The Gaithersburg, Md.-based company said that its quarterly revenues would rise from $11.6 million in first-quarter 2002, to $15.4 million in the second quarter, to $17.2 million in the third, and to $20.8 million in the fourth.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.